|
|
Effect of acupuncture combined with Wenpi Tongluo Kaiqiao Decoction in the treatment of vascular dementia with syndrome of phlegm turbidity obstructing the orifices#br# |
GUO Zheng1 SHI Bin2,3 WANG Cong’an2 WANG Yang1 ZHOU Jiahui1 |
1.Department of Rehabilitation, Fuxin Mine General Hospital of Liaoning Health Industry Group, Liaoning Province, Fuxin 123000, China;
2.Department of Rehabilitation, Neck Shoulder Lumbar Leg Pain Hospital Affiliated to Shandong First Medical University, Shandong Province, Jinan 250031, China;
3.Department of Rrthopedics and Traumatology of Traditional Chinese Medicine, Shandong Medical Biotechnology Research Center, Shandong Province, Jinan 250062, China |
|
|
Abstract Objective To explore the effect of acupuncture combined with Wenpi Tongluo Kaiqiao Decoction in the treatment of vascular dementia (VD) with syndrome of phlegm turbidity obstructing the orifices. Methods A total of 113 VD patients with syndrome of phlegm turbidity obstructing the orifices admitted to Fuxin Mine General Hospital of Liaoning Health Industry Group from January 2018 to March 2021 were selected as the research subjects. According to the random number table method, the patients were divided into control group (56 cases) and experimental group (57 cases). The control group was treated with conventional Western medicine and acupuncture, and the experimental group was treated with Wenpi Tongluo Kaiqiao Decoction on the basis of the control group, both groups were treated for 12 weeks. The clinical efficacy, traditional Chinese medicine syndrome score, mini-mental state examination (MMSE) scale, Hasegawa dementia scale (HDS), activities of daily living (ADL) scale, interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNF-α) in the two groups were compared, the incidence of adverse reactions were observed. Results After treatment, the total effective rate of the experimental group was higher than that in the control group (P < 0.05). After treatment, the headache with binding sensation score, hypophrenia score, anorexia and abdominal distension score, silence score, slow movement score, and vomiting score in the two groups were decreased, which in the experimental group were lower than those in the control group (P < 0.05). After treatment, the MMSE, HDS, and ADL scores in the two groups were increased, which in the experimental group were higher than those in the control group (P < 0.05). After treatment, the levels of serum IL-6 and TNF-α in the two groups were decreased, and which in the experimental group were lower than those in the control group (P < 0.05), the VEGF levels in the two groups were increased, which in the experimental group was higher than that in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions in the two groups (P > 0.05). Conclusion Acupuncture combined with Wenpi Tongluo Kaiqiao Decoction in the treatment of VD patients with syndrome of phlegm turbidity obstructing the orifices can rapidly improve the clinical symptoms, has definite curative effect, can reduce inflammatory factors, improve the ability of life, cognitive function and neurological function.
|
|
|
|
|
[1] 陈乐,周华东.血管性痴呆的研究进展[J].西南军医,2019,21(5):437-440.
[2] 吴家民,林颖琦,李昕豪,等.电针与尼莫地平治疗血管性痴呆临床疗效差异Meta分析[J].针灸临床杂志,2018, 34(12):51-55,95.
[3] 杨梦琳,张运辉,伍大华.中药复方防治血管性痴呆的实验研究进展[J].中医药信息,2019,36(4):113-116.
[4] 吕立峰,亓爱芹,李秀芹.温脾通络开窍汤联合丁苯酞治疗老年血管性痴呆的疗效及对高血浆同型半胱氨酸、炎症因子的影响[J].中华中医药学刊,2018,36(5):1262-1265.
[5] 潘攀,凌真真,张雪竹.针刺治疗血管性痴呆机制的研究进展[J].吉林中医药,2020,40(3):406-409.
[6] 中华医学会神经病学分会.血管性痴呆诊断标准草案[J].中华神经科杂志,2002,35(4):246-246.
[7] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:93.
[8] 田荣,贾秀丽.简易智能精神状态检查量表检测对痴呆患者临床护理的指导作用[J].临床医学研究与实践,2018,3(17):159-160.
[9] 周玮,洪紫静,胡蓉蓉,等.老年人失智失能检测工具的修订与信效度检测[J].中国健康心理学杂志,2019,27(3):453-456.
[10] 刘帅,柳净,陈慧,等.阿尔茨海默病与血管性痴呆患者认知及日常生活能力对比分析[J].山东医药,2015,55(19):32-34.
[11] 唐毅.阿尔茨海默病中国负担及非药物治疗[J].中国药理学与毒理学杂志,2019,33(6):403-404.
[12] Smith EE. Clinical presentations and epidemiology of vascular dementia [J]. Clin Sci(Lond),2017,131(11):1059-1068.
[13] 申海玉,查青,张慧楠,等.血管性痴呆治疗的相关研究进展[J].西北药学杂志,2020,35(6):976-979.
[14] 董新刚,叶险峰,王小璐,等.血管性痴呆肾精亏虚合痰瘀互结证方药探析[J].河南医学研究,2019,28(24):4417-4419.
[15] 吴林,杨进平,温惠娟,等.温脾通络开窍法对阿尔茨海默病大鼠学习记忆及海马Tau蛋白磷酸化表达的影响[J].中西医结合心脑血管病杂志,2013,11(10):1238-1241.
[16] 寿津,谢渭根.多奈哌齐与尼莫地平联合治疗老年期血管性痴呆的效果分析[J].中国现代医生,2021,59(1):91-94.
[17] 孙磊,孟锦,赵宏伟,等.不同剂量阿伐他汀联合阿司匹林治疗原发性高血压并动脉粥样硬化的临床研究[J].现代生物医学进展,2018,18(4):681-684.
[18] 徐婧,程岩岩,张立德,等.中医治法在血管性痴呆中的应用[J].世界中医药,2021,16(8):1333-1337,1342.
[19] 陆正齐.炎症、免疫与脑血管病的研究进展[J].中山大学学报:医学科学版,2021,42(1):11-16.
[20] 黄忠,高国勋,曾义,等.老年痴呆患者脂糖代谢指标及血清CRP、IL-6和TNF-α的表达及临床意义[J].现代生物医学进展,2020,20(14):2740-2744.
[21] 拜承萍,铁婷婷.HMGB1、MIF和TNF-α在血管性痴呆患者血清中的表达及价值分析[J].国际检验医学杂志,2019,40(13):1615-1618.
[22] 王御林,高元杰,钟纯正,等.血管性痴呆患者血清mi R-34a和VEGF的表达及临床意义[J].脑与神经疾病杂志,2020,28(3):155-158.
[23] 林文新,黄丽平,邓敏贞,等.益智仁和砂仁有效成分对岗田酸诱导阿尔兹海默病细胞模型的作用研究[J].中医学报,2018,33(1):106-110.
[24] 邱咏园,唐映红,王蓓,等.黄芪和三七4种有效成分配伍对小鼠脑缺血再灌注早期抗氧化应激物质活性的影响[J].中华中医药杂志,2014,29(6):1940-1943.
[25] 杨海淦,曹蕊,王茂杰,等.石菖蒲水提取物对人脑神经胶质细胞NO表达的影响[J].中国医药导报,2019,16(25):24-26,31. |
|
|
|